Evidence map›Paper›PMID 30931641›Full record

ArticleAmyotrophic lateral sclerosis & frontotemporal degeneration2019

Telomere length is greater in ALS than in controls: a whole genome sequencing study.

Ahmad Al Khleifat, Alfredo Iacoangeli, Aleksey Shatunov, Ton Fang, William Sproviero, Ashley R Jones, Sarah Opie-Martin, Karen E Morrison, Pamela J Shaw, Christopher E Shaw and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Amyotrophic lateral sclerosis & frontotemporal degeneration, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Evaluation of the Telomere Length in Patients with Spinal Muscular Atrophy.International journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Ahmad Al Khleifata Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.ORCID 0000-0002-7406-9831
Alfredo Iacoangelia Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.ORCID 0000-0002-5280-5017
Aleksey Shatunova Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.
Ton Fanga Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.
William Sprovieroa Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.
Ashley R Jonesa Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.
Sarah Opie-Martina Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.
Karen E Morrisonc Faculty of Medicine , University of Southampton, University Hospital Southampton NHS Foundation Trust , Southampton , UK.
Pamela J Shawd Sheffield Institute for Translational Neuroscience, University of Sheffield , Sheffield , UK.ORCID 0000-0002-8925-2567
Christopher E Shawa Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.
John F Powella Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.
Richard Dobsonb Department of Biostatistics and Health Informatics , King's College London , London , UK.
Steven J Newhouseb Department of Biostatistics and Health Informatics , King's College London , London , UK.
Ammar Al-Chalabia Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.ORCID 0000-0002-4924-7712
King's College London · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Sheffield · GB

Funding

Medical Research Council G0500289Medical Research Council G0600974Medical Research Council G0900635Medical Research Council G0900688Medical Research Council G1100695Medical Research Council MC_G1000733Medical Research Council MC_PC_17115Medical Research Council MC_PC_17214Medical Research Council MR/L021803/1Medical Research Council MR/L501529/1Medical Research Council MR/R024804/1Motor Neurone Disease Association AL-CHALABI/APR15/844-791Motor Neurone Disease Association ALCHALABI-DOBSON/APR14/829-791Motor Neurone Disease Association ALCHALABI-TALBOT/APR14/926-794Motor Neurone Disease Association JONES/OCT15/958-799Motor Neurone Disease Association SHAW/NOV14/985-797Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAge of OnsetAmyotrophic Lateral SclerosisCase-Control StudiesComputational BiologyDNAFemaleGenetic VariationHumansIntronsLeukocytesMaleMiddle AgedPolymorphism, Single NucleotideSurvival AnalysisTelomereDNA

Identifiers

PMID30931641
PMCPMC6567548
OpenAlexW2926956219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.